Recent advances in antifungal agents.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Mini-Reviews in Medical Chemistry

• Publication date

  2007-08-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/138955707781662672PMID 17897080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sordarin Derivatives Induce a Novel Conformation of the Yeast Ribosome Translocation Factor eEF2*

  2007cited by this paper
• Combination antifungal therapy for invasive aspergillosis - Is it indicated?

  2006cited by this paper
• Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis

  2006cited by this paper
• Infectious disease update: new anti-microbials.

  2006cited by this paper
• Posaconazole as Salvage Therapy for Zygomycosis

  2006cited by this paper
• The discovery of moriniafungin, a novel sordarin derivative produced by Morinia pestalozzioides.

  2006cited by this paper
• Synthesis of (-)-sordarin.

  2006cited by this paper
• Hydroxylated analogues of the orally active broad spectrum antifungal, Sch 51048 (1), and the discovery of posaconazole [Sch 56592; 2 or (S,S)-5].

  2006cited by this paper
• Clinical efficacy of new antifungal agents.

  2006cited by this paper
• In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance

  2006cited by this paper
• Aspergillosis: spectrum of disease, diagnosis, and treatment.

  2006cited by this paper
• International Surveillance of Candida spp. and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2003)

  2006cited by this paper
• Potential fungicidal effect of voriconazole against Candida spp.

  2005cited by this paper
• Anidulafungin: a new echinocandin with a novel profile.

  2005cited by this paper
• Role of new antifungal agents in prophylaxis of mycoses in high risk patients

  2005cited by this paper
• Posaconazole: a broad-spectrum triazole antifungal.

  2005cited by this paper
• Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection.

  2005cited by this paper
• Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.

  2005cited by this paper
• Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. Isolates

  2005cited by this paper
• A phase I/II randomized, double‐blind, placebo‐controlled, dose‐ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis

  2005cited by this paper
• Antifungal Activities of R-135853, a Sordarin Derivative, in Experimental Candidiasis in Mice

  2005cited by this paper
• A pathway‐specific transcriptional regulatory gene for nikkomycin biosynthesis in Streptomyces ansochromogenes that also influences colony development

  2005cited by this paper
• Antifungal treatment in pediatric patients.

  2005cited by this paper
• Update on antifungal drug resistance mechanisms of Aspergillus fumigatus.

  2005cited by this paper
• Second-generation dimeric inhibitors of chitin synthase.

  2004cited by this paper
• Pharmacokinetics of Posaconazole Coadministered with Antacid in Fasting or Nonfasting Healthy Men

  2004cited by this paper
• Newer systemic antifungal agents : pharmacokinetics, safety and efficacy.

  2004cited by this paper
• In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus.

  2004cited by this paper
• Design, synthesis and biological evaluation of hetaryl-nucleoside derivatives as inhibitors of chitin synthase.

  2003cited by this paper
• Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole

  2003cited by this paper
• Microbial natural products as a source of antifungals.

  2003cited by this paper
• Antifungal agents: mechanisms of action.

  2003cited by this paper
• Echinocandin antifungal drugs.

  2003cited by this paper
• In vitro susceptibilities of zygomycetes to conventional and new antifungals.

  2003cited by this paper
• Antifungal sordarins. part 3: synthesis and structure-activity relationships of 2',3'-fused oxirane derivatives.

  2002cited by this paper
• Oxime derivatives of sordaricin as potent antifungal agents.

  2002cited by this paper
• Inhibitory effect of nikkomycin Z on chitin synthases in Candida albicans

  2002cited by this paper
• Antifungal drug resistance of pathogenic fungi.

  2002cited by this paper
• Synthesis of Sordaricin analogues as potent antifungal agents against Candida albicans.

  2002cited by this paper
• Synthesis and evaluation of N-substituted 1,4-oxazepanyl Sordaricins as selective fungal EF-2 inhibitors.

  2002cited by this paper
• Infectious disease 2001: drug resistance, new drugs.

  2002cited by this paper
• Antifungal Sordarins. Part 4: synthesis and structure--activity relationships of 3',4'-fused alkyl-tetrahydrofuran derivatives.

  2002cited by this paper
• Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

  2002cited by this paper
• Safety and Pharmacokinetics of Oral Voriconazole in Patients at Risk of Fungal Infection: A Dose Escalation Study

  2002cited by this paper
• Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of Aspergillus spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000

  2002cited by this paper
• Structure--function characterization of cellulose synthase: relationship to other glycosyltransferases.

  2001cited by this paper
• Substrate recognition sites in 14alpha-sterol demethylase from comparative analysis of amino acid sequences and X-ray structure of Mycobacterium tuberculosis CYP51.

  2001cited by this paper
• Fungal beta(1,3)-D-glucan synthesis.

  2001cited by this paper
• FR131535, a novel water-soluble echinocandin-like lipopeptide: synthesis and biological properties.

  2001cited by this paper
• Chitin synthesis in human pathogenic fungi.

  2001cited by this paper
• Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

  2001cited by this paper
• In Vitro Activities of Posaconazole (Sch 56592) Compared with Those of Itraconazole and Fluconazole against 3,685 Clinical Isolates of Candida spp. andCryptococcus neoformans

  2001cited by this paper
• Novel nikkomycin analogues: inhibitors of the fungal cell wall biosynthesis enzyme chitin synthase.

  2000cited by this paper
• The discovery of enfumafungin, a novel antifungal compound produced by an endophytic Hormonema species biological activity and taxonomy of the producing organisms.

  2000cited by this paper
• In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens.

  2000cited by this paper
• In Vitro Pharmacodynamic Parameters of Sordarin Derivatives in Comparison with Those of Marketed Compounds against Pneumocystis carinii Isolated from Rats

  2000cited by this paper
• Activities of Sordarins in Experimental Models of Candidiasis, Aspergillosis, and Pneumocystosis

  2000cited by this paper
• A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).

  2000cited by this paper
• Voriconazole: A New Triazole Antifungal

  2000cited by this paper
• FK463, a novel water-soluble echinocandin lipopeptide: synthesis and antifungal activity.

  1999cited by this paper
• Novel antifungal drugs.

  1999cited by this paper
• Mutations in Ribosomal Protein L10e Confer Resistance to the Fungal-specific Eukaryotic Elongation Factor 2 Inhibitor Sordarin*

  1999cited by this paper
• Alkyl side-chain derivatives of sordaricin as potent antifungal agents against yeast.

  1998cited by this paper
• Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts

  1998cited by this paper
• Antifungals: mechanism of action and resistance, established and novel drugs.

  1998cited by this paper
• Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance

  1998cited by this paper
• Panfungal PCR Assay for Detection of Fungal Infection in Human Blood Specimens

  1998cited by this paper
• Characterization of Saccharomyces cerevisiae CYP61, Sterol Δ22-Desaturase, and Inhibition by Azole Antifungal Agents*

  1997cited by this paper
• The search for new triazole antifungal agents.

  1997cited by this paper
• Ascosteroside, a new antifungal agent from Ascotricha amphitricha. I. Taxonomy, fermentation and biological activities.

  1996cited by this paper
• Fungal beta-glucan interacts with vitronectin and stimulates tumor necrosis factor alpha release from macrophages

  1996cited by this paper
• Semisynthetic chemical modification of the antifungal lipopeptide echinocandin B (ECB): structure-activity studies of the lipophilic and geometric parameters of polyarylated acyl analogs of ECB.

  1995cited by this paper
• P450 inhibitors of use in medical treatment: focus on mechanisms of action.

  1995cited by this paper
• Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form

  1995cited by this paper
• Biochemistry and molecular biology of the human CYP2C subfamily.

  1994cited by this paper
• The function of chitin synthases 2 and 3 in the Saccharomyces cerevisiae cell cycle

  1991cited by this paper
• Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis

  1990cited by this paper
• Anti-Candida activity of polyoxin: example of peptide transport in yeasts

  1984cited by this paper
• In vitro and in vivo anti-Candida activity and toxicology of LY121019.

  1984cited by this paper
• [Isolation and decomposition of sordarin].

  1971cited by this paper

• A systematic review to understand the current scenarios employing plants and their secondary metabolites as antifungal agents: opportunities and challenges

  2026cites this paper
• Combinatorial Antimicrobial Effects of Imidazolium-Based Ionic Liquids and Antifungals on Model Fungal Organisms

  2025cites this paper
• Comprehensive review of fungal pathogenesis and antifungal therapeutics

  2025cites this paper
• Recent advances in topical carriers of anti-fungal agents

  2020cites this paper
• Legacy and Innovative Treatment: Projected Modalities for Antimicrobial Intervention

  2020cites this paper
• Natural Products Incorporating Pyrimidine Nucleosides

  2020cites this paper
• COMPARATIVE IN VITRO EVALUATION OF BRANDS OF CLOTRIMAZOLE CREAM FORMULATIONS MARKETED IN ETHIOPIA

  2018cites this paper
• Design, synthesis and biological evaluation of novel quinazoline-2,4-diones conjugated with different amino acids as potential chitin synthase inhibitors.

  2018cites this paper
• Antifungals

  2017cites this paper
• Medicinal uses of Galenia africana: A study of the antimicrobial, antifungal and anticancer properties

  2017cites this paper
• Glycotriazole-peptides derived from the peptide HSP1: synergistic effect of triazole and saccharide rings on the antifungal activity

  2017cites this paper
• Fungi Fights Fungi: Tip-off in Antifungal Chemotherapy

  2016cites this paper
• Fatal Pneumocystis jirovecii pneumonia in a HIV-negative adult

  2015cites this paper
• Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001-2011).

  2014cites this paper
• Synthesis and antifungal activity of ASP9726, a novel echinocandin with potent Aspergillus hyphal growth inhibition.

  2014cites this paper
• Design, synthesis and evaluation of novel quinazoline-2,4-dione derivatives as chitin synthase inhibitors and antifungal agents.

  2014cites this paper
• Clotrimazole as a pharmaceutical: past, present and future.

  2014cites this paper
• Antidermatophytic activities, Phytochemical nscreening and Chromatographic studies of Pergularia tomentosa L. and Mitracarpus scaber Zucc. (Leaves) Used in the Treatment of Dermatophytoses

  2013cites this paper
• Antifungal activity of seeds of Alangium salvifolium (L.f.)Wangerin (Alangiaceae)

  2013cites this paper
• Synthetic Studies on Antifungal Peptidyl Nucleoside Antibiotics

  2013cites this paper
• The biology and chemistry of antifungal agents: a review.

  2012cites this paper
• Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis

  2011cites this paper
• The Potential of Antimicrobial Peptides as Biocides

  2011cites this paper
• Non-β-Lactam Antibiotics

  2011cites this paper
• The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis.

  2011cites this paper
• Use of Fish Cell Cultures for the Study and Cultivation of Microsporidia

  2011cites this paper
• Aspartic protease inhibitors as potential anti-Candida albicans drugs: impacts on fungal biology, virulence and pathogenesis.

  2011cites this paper
• Synthesis and biological activities of novel amine-derived bis-azoles as potential antibacterial and antifungal agents.

  2010cites this paper
• Synthesis of Novel Halobenzyloxy and Alkoxy 1,2,4-Triazoles and Evaluation for Their Antifungal and Antibacterial Activities

  2010cites this paper
• Progress towards the Synthesis of Sordarin and its Analogs

  2010cites this paper
• Antimicrobial nucleoside antibiotics targeting cell wall assembly: recent advances in structure-function studies and nucleoside biosynthesis.

  2010cites this paper
• Mutations causing Greenberg dysplasia but not Pelger anomaly uncouple enzymatic from structural functions of a nuclear membrane protein

  2010cites this paper
• Antifungal agents, WO2009025733

  2010cites this paper
• FR290581, a novel sordarin derivative: synthesis and antifungal activity.

  2009cites this paper
• Studies on peptidyl nucleoside antibiotics: synthesis and antifungal evaluation of pyranosyl nucleoside analogs of nikkomycin.

  2009cites this paper
• [Pharmacodynamics and pharmacokinetics of micafungin in adults, children and neonate].

  2009cites this paper
• Peptide antibiotics: an alternative and effective antimicrobial strategy to circumvent fungal infections.

  2009cites this paper
• Patent evaluation Antifungal agents , WO 2009025733 Pore

  2009cites this paper
• Penetration of 1% voriconazole eye drops into human vitreous humour: a prospective, open‐label study

  2009cites this paper
• Severe Mycoses in Immunodepressed Patients

  2009cites this paper
• A monoclonal IgM directed against immunodominant catalase B of cell wall of Aspergillus fumigatus exerts anti‐A. fumigatus activities

  2009cites this paper
• Adverse reactions to antifungal agents

  2008cites this paper
• Antifungal Activity and Phytochemical Analysis of Column Chromatographic Fractions of Stem Bark Extracts of Ficus sycomorus L. (Moraceae)

  2007cites this paper
• Nutritive Value, Phytochemical and Antifungal Properties of Pergularia tomentosa L. (Asclepiadaceae)

  2007cites this paper
• Evaluation of Antifungal Activity and Phytochemical Analysis of Leaves, Roots and Stem Barks Extracts of Calotropis procera (Asclepiadaceae)

  2006cites this paper
• Monoclonal Immunoglobulin G1 Directed against Aspergillus fumigatus Cell Wall Glycoprotein Protects against Experimental Murine Aspergillosis

  2005cites this paper